Literature DB >> 33904985

Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis.

Hyeok Choi1, Yong-Beom Park2, Jaewoo Song3, Sang-Won Lee4.   

Abstract

BACKGROUND AND
OBJECTIVE: Antineutrophil cytoplasmic antibody (ANCA) is a specific autoantibody for ANCA-associated vasculitis (AAV). However, ANCA can be detected in various diseases other than AAV. Hence, in this study, we investigated and provided the name of diseases with repeated ANCA positivity and the frequency of each disease other than AAV.
METHODS: We retrospectively screened the results of the tests of ANCA in 26,499 patients using the Clinical Data Repository System and included in this study only 173 patients with repeated ANCA positivity more than twice. 'Unclassifiable ANCA' was defined when ANCA was detected in patients with diseases other than AAV. 'Unclassifiable repeated ANCA' was also defined when unclassifiable ANCA was successively detected more than twice.
RESULTS: Among rheumatic and autoimmune diseases, the most common disease with unclassifiable repeated ANCA was vasculitis undetermined (21.0%). In terms of cardiovascular and cerebrovascular diseases, the most common disease with unclassifiable repeated ANCA was atherosclerotic heart disease (12.1%). In terms of disorders in liver, kidneys and lungs, the most common disease with unclassifiable repeated ANCA was chronic kidney disease (51 cases, 29.5%). In addition, among infections with confirmed infectious pathogens, the most common pathogen with unclassifiable repeated ANCA was varicella-zoster virus (6.9%) followed by Candida (4.6%).
CONCLUSION: Overall, regardless of category, the common diseases with unclassifiable repeated ANCA were chronic kidney disease followed by interstitial lung disease and vasculitis undetermined. Thus, we carefully suggest that physicians should pay more attention to the development of AAV or vasculitis other than AAV and, furthermore, kidneys and lungs should be monitored regularly and closely in patients with unclassifiable repeated ANCA.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Antineutrophil cytoplasmic antibody; Chronic kidney disease; Interstitial lung disease; Positivity; Vasculitis

Mesh:

Substances:

Year:  2021        PMID: 33904985     DOI: 10.1007/s00393-021-00998-1

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.530


  2 in total

1.  Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis.

Authors:  Dhanita Khanna; Amita Aggarwal; Darshan S Bhakuni; Rajeshwar Dayal; Ramnath Misra
Journal:  J Rheumatol       Date:  2003-06       Impact factor: 4.666

Review 2.  Neutrophil anti-neutrophil cytoplasmic autoantibody proteins: bactericidal increasing protein, lactoferrin, cathepsin, and elastase as serological markers of inflammatory bowel and other diseases.

Authors:  Kallirroi S Kyriakidi; Vasileios E Tsianos; Evaggelos Karvounis; Dimitrios K Christodoulou; Konstantinos H Katsanos; Epameinondas V Tsianos
Journal:  Ann Gastroenterol       Date:  2016-03-24
  2 in total
  1 in total

1.  Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2.

Authors:  Lucy Eunju Lee; Wooyong Jeong; Yong-Beom Park; Su Jin Jeong; Sang-Won Lee
Journal:  J Clin Med       Date:  2022-07-17       Impact factor: 4.964

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.